Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors

摘要

The present disclosure particularly provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, which is a modulator of the C5a receptor. Pharmaceutical compositions and methods of use are also provided, including the treatment and non-pharmaceutical applications of diseases or disorders involving pathological activation from C5a.